X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (245) 245
humans (240) 240
female (201) 201
breast cancer (166) 166
breast neoplasms - drug therapy (137) 137
middle aged (132) 132
adult (115) 115
chemotherapy (113) 113
aged (110) 110
breast neoplasms - pathology (106) 106
cancer (91) 91
antineoplastic combined chemotherapy protocols - therapeutic use (70) 70
treatment outcome (64) 64
care and treatment (58) 58
survival (55) 55
metastasis (53) 53
disease-free survival (48) 48
trastuzumab (48) 48
aged, 80 and over (46) 46
antineoplastic agents - therapeutic use (46) 46
medicine & public health (46) 46
therapy (46) 46
antineoplastic combined chemotherapy protocols - adverse effects (40) 40
women (40) 40
breast neoplasms - metabolism (39) 39
neoplasm metastasis (39) 39
patients (37) 37
breast neoplasms - mortality (36) 36
neoplasm staging (36) 36
prognosis (36) 36
tumors (36) 36
clinical trials (34) 34
antineoplastic agents - adverse effects (33) 33
receptor, erbb-2 - metabolism (33) 33
research (31) 31
cancer therapies (30) 30
quality of life (29) 29
breast neoplasms - genetics (28) 28
metastases (28) 28
paclitaxel (28) 28
analysis (27) 27
bevacizumab (27) 27
risk factors (27) 27
health aspects (26) 26
hematology, oncology and palliative medicine (26) 26
metastatic breast cancer (26) 26
postmenopausal women (26) 26
abridged index medicus (24) 24
double-blind (24) 24
expression (24) 24
capecitabine (23) 23
endocrine therapy (23) 23
risk (23) 23
tamoxifen (23) 23
breast-cancer (22) 22
efficacy (22) 22
safety (22) 22
breast neoplasms - therapy (21) 21
toxicity (21) 21
trial (21) 21
cancer research (20) 20
chemotherapy, adjuvant (20) 20
combination (20) 20
drug therapy (20) 20
clinical trials as topic (19) 19
male (19) 19
oncology, experimental (19) 19
receptors, estrogen - metabolism (19) 19
adjuvant chemotherapy (18) 18
endothelial growth-factor (18) 18
epidermal growth factor (18) 18
erbb-2 protein (18) 18
everolimus (18) 18
medicine, general & internal (18) 18
neoadjuvant therapy (18) 18
survival analysis (18) 18
antibodies, monoclonal, humanized (17) 17
kaplan-meier estimate (17) 17
usage (17) 17
animals (16) 16
cancer patients (16) 16
double-blind method (16) 16
letrozole (16) 16
patient outcomes (16) 16
prevention (16) 16
quality-of-life (16) 16
surgery (16) 16
survival rate (16) 16
young adult (16) 16
antibodies, monoclonal, humanized - administration & dosage (15) 15
antineoplastic agents (15) 15
breast neoplasms - diagnosis (15) 15
drug administration schedule (15) 15
gene expression (15) 15
her2 (15) 15
paclitaxel - administration & dosage (15) 15
antibodies, monoclonal - adverse effects (14) 14
carcinoma (14) 14
disease progression (14) 14
follow-up studies (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 1, pp. 23 - 34
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 4, pp. 398 - 405
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 21, pp. 2615 - 2623
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 4, pp. 371 - 372
Breast cancer is the most common cancer diagnosis in young women. 1 In the United States, the incidence of breast cancer among women under the age of 50 is... 
MEDICINE, GENERAL & INTERNAL | Outcome and process assessment (Health Care) | Care and treatment | Usage | Breast cancer | Hormone therapy | Analysis | Menopause | Cyclin-dependent kinases | Endocrine therapy | Metastasis | Cancer therapies | Cyclin-dependent kinase 4 | Chemotherapy | Womens health | Medical prognosis | Diagnosis | Health risk assessment | Neutropenia
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 4, pp. 628 - 633
Journal Article
Journal Article
Journal of Italian Cinema & Media Studies, ISSN 2047-7368, 03/2013, Volume 1, Issue 2, pp. 129 - 141
This article identifies Marco Ferreri's original contribution to cinema as a gesture aimed at exposing the 'end of the world'. This expression should be... 
Marco Ferreri | monuments | end of the world | neo-realism | sense | hope | essential images | hope sense | Neorealism | Ferreri, Marco | film | dramatic arts
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 22, pp. 2108 - 2121
Journal Article